The strong revenue growth, particularly in the high-margin Data and Applications segment (30.9% YoY), combined with the significant improvement in Adjusted EBITDA (turning positive in Q4), suggests the company is scaling efficiently. The 2026 guidance indicates continued strong growth and improving profitability, making this a key catalyst for investor interest. Monitor the sustainability of the 121.6% Diagnostics growth and the expansion of the $1.1 billion Total Remaining Contract Value.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Feb 25 $53.71entry
- T+1 · 9mo ago +3.17%α +3.71% · $55.41
- T+5 · 9mo ago −4.51%α −3.41% · $51.29
- T+20 · 8mo ago −12.94%α −7.70% · $46.76
- T+60 · 6mo ago −14.58%α −21.53% · $45.88
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Tempus AI reported strong fourth quarter and full year 2025 results with revenue of $367.2 million (up 83.0% YoY) and full-year revenue of $1.3 billion (up 83.4% YoY), driven by 121.6% growth in Diagnostics and 30.9% growth in Data and Applications. The company achieved positive Adjusted EBITDA of $12.9 million in Q4 and provided 2026 revenue guidance of $1.59 billion (~25% growth) with expected Adjusted EBITDA of ~$65 million.
Key Financial Metrics
Key Facts
- Q4 revenue of $367.2 million, up 83.0% year-over-year with 33.5% organic growth (excluding Ambry)
- Diagnostics revenue of $266.9 million in Q4, representing 121.6% year-over-year growth
- Data and Applications revenue of $100.4 million in Q4, representing 25.1% year-over-year growth
- Adjusted EBITDA improved to $12.9 million in Q4, compared to ($7.8 million) in Q4 2024
- Full year 2025 revenue increased 83.4% to $1.3 billion
- 2026 revenue guidance of $1.59 billion (~25% annual growth) and Adjusted EBITDA of ~$65 million
- Ended year with over $1.1 billion in Total Remaining Contract Value and 126% Net Revenue Retention
Financial Impact
Revenue growth of 83% in 2025 with strong guidance for 25% growth in 2026 and path to profitability (positive Adjusted EBITDA in Q4)
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| Diagnostics | $955.4M | +111.5% |
| Data and Applications | $316.4M | +30.9% |
Risk Factors
- The company reported a net loss of $245 million for the full year 2025, indicating it is not yet profitable on a GAAP basis.
- The guidance is for Adjusted EBITDA, not net income, and the company does not provide net loss guidance, leaving uncertainty about the path to GAAP profitability.
- The business has significant debt, including $728 million in convertible senior notes, which could pose a risk if growth slows or interest rates rise.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 11 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (TEM), Batch item 1 | 0001193125-26-066931 |
| Document: tem-20260224.htm | 0001193125-26-066931 |
| Document: 0001193125-26-066931-index-headers.html | 0001193125-26-066931 |
| Document: 0001193125-26-066931-index.html | 0001193125-26-066931 |
| Document: 0001193125-26-066931.txt | 0001193125-26-066931 |
| 8-K Filing (TEM), Batch item 6 | 0001193125-26-066931 |
| Document: tem-20260224.htm | 0001193125-26-066931 |
| Document: 0001193125-26-066931-index-headers.html | 0001193125-26-066931 |
| Document: 0001193125-26-066931-index.html | 0001193125-26-066931 |
| Document: 0001193125-26-066931.txt | 0001193125-26-066931 |
| CONTEXT: Previous Earnings (2026-02-24) | 0001193125-26-066931 |
Track record
45 reports on TEM
8 of 9 bullish or bearish reports moved the stock their way by T+60. Best: +53.09% at T+60 after the Jul 30, 2026 report. 16 of 17 went positive at some point.
Filters
- Nov 9, 20267d ago Press Release Neutral 3/10 Entry $80.54 Now $64.76 −19.59% settles Feb 8
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $76.05 Now $64.76 −14.85% settles Feb 4
- Nov 4, 202612d ago Insider Cluster Neutral 3/10 Entry $70.43 Now $64.76 −8.05% settles Feb 3
- Nov 2, 202614d ago 144 Neutral 1/10 Entry $77.80 Now $64.76 −16.76% settles Feb 1
- Nov 2, 202614d ago 8-K Bullish 6/10 Entry $78.48 Now $64.76 −17.48% settles Jan 29
- Oct 28, 202619d ago SC 13G/A Neutral 2/10 Entry $77.84 Now $64.76 −16.80% settles Jan 27
- Oct 28, 202619d ago Institutional Cluster Neutral 3/10 Entry $76.61 Now $64.76 −15.47% settles Jan 26
- Oct 27, 202620d ago 144 Neutral 3/10 Entry $76.61 Now $64.76 −15.47% settles Jan 26
- Oct 23, 202624d ago 8-K Bullish 6/10 Entry $67.62 Now $64.76 −4.22% settles Jan 21
- Oct 22, 202626d ago EFFECT Neutral 4/10 Entry $63.81 Now $64.76 +1.49% settles Jan 20
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers